Related references
Note: Only part of the references are listed.Effect of a Dual Trigger Using a GnRH Agonist and hCG on the Cumulative Live-Birth Rate for Normal Responders in GnRH-Antagonist Cycles
Fumei Gao et al.
FRONTIERS IN MEDICINE (2021)
Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study
George T. Lainas et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2020)
GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study
J. Haas et al.
HUMAN REPRODUCTION (2020)
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment
Ali Abbara et al.
ENDOCRINE REVIEWS (2018)
Human chorionic gonadotropin serum levels following ovulation triggering and IVF cycle outcome
Yossi Mizrachi et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2018)
The correlation between raised body mass index and assisted reproductive treatment outcomes: a systematic review and meta-analysis of the evidence
Prasanna Raj Supramaniam et al.
REPRODUCTIVE HEALTH (2018)
Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index
Carlo Alviggi et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
hCG Triggering in ART: An Evolutionary Concept
Anat Hershko Klement et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study
Thi Ngoc Lan Vuong et al.
FERTILITY AND STERILITY (2016)
Pharmaceutical Options for Triggering of Final Oocyte Maturation in ART
Juan Carlos Castillo et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes
R. Matorras et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2012)
Oocyte morphological abnormalities in overweight women undergoing in vitro fertilization cycles
Raffaella Depalo et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
An OHSS-Free Clinic by segmentation of IVF treatment
Paul Devroey et al.
HUMAN REPRODUCTION (2011)
A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index
Semra Kahraman et al.
FERTILITY AND STERILITY (2010)
Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotrop in-releasing hormone antagonists and recombinant follicle-stimulating hormone
Efstratios M. Kolibianakis et al.
FERTILITY AND STERILITY (2007)
Obstetric outcomes after in vitro fertilization in obese and morbidly obese women
Anuja Dokras et al.
OBSTETRICS AND GYNECOLOGY (2006)
Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women
CCW Chan et al.
HUMAN REPRODUCTION (2003)
Use of recombinant human chorionic gonadotropin in ovulation induction
M Ludwig et al.
FERTILITY AND STERILITY (2003)
Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology:: Results of a clinical trial comparing two doses of rhCG (Ovidrel®) to urinary hCG (Profasi®) for induction of final follicular maturation in in vitro fertilization-embryo transfer
P Chang et al.
FERTILITY AND STERILITY (2001)